Paper Review Records
All Paper Review Records
21 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
Correspondence: Reply to “Heterogeneity in dosages and treatment conditions forms a blurred picture of the results”
Muhammad Hussain; Muhammad Hassan; Asharib Sohaib; Taha Ahmed; Saifullah Khan; Abdul Hannan; Hassan Abdul Aziz Dhedhi; Asma Naz; Ameer Haider Cheema; Faizan AhmedShow moreShow less
1. Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan; 2. University of Texas Southwestern, Dallas, USA; 3. Hackensack Meridian Health Jersey, Shore University Medical Center, Neptune, USAShow moreShow less
Body mass index and psychotropic drug concentrations in eating disorders: methodological considerations and clinical implications
Priyanka Ochani; Ayushman Ochani; Konain Fatima; Rubaisha NaeemShow moreShow less
1. Liaquat University of Medical and Health Sciences, Jamshoro, PakistanShow moreShow less
Efficacy and safety of GLP-1 receptor agonists for antipsychotic-related overweight and metabolic dysregulation: a systematic review and meta-analysis
Lingyan Zhou; Ying Zhang; Chao Shen; Fengbo WuShow moreShow less
1. Department of Pharmacy, West China Hospital, Sichuan University, Chengdu, ChinaShow moreShow less
GLP-1-based therapies in cardiovascular disease: outcomes, mechanisms, and emerging clinical applications
Rachelle Jang; Michelle Jang; Xinyuan Ruan; Caden Jin; Woo KimShow moreShow less
1. Crescenta Valley High School, La Crescenta, USA; 2. Tarbut V’Torah Community Day School, Irvine, USA; 3. San Marino High School, San Marino, USA; 4. Tufts Medical Center, Boston, USAShow moreShow less
Timing between public safety signals and label strengthening in targeted oncology therapies
Xiaogao Zhang; Xiaoyun Wang; Jie WangShow moreShow less
1. Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaShow moreShow less
Efficacy and Safety of Argatroban as an Adjunct to Antiplatelet Therapy in Ischemic Stroke: An Updated Systematic Review and Meta-analysis
Syeda Takreem Fatima; Ahmed Raza; Abdullah Javed; Shabnam Ijaz; Mishaal Noor; Syeda Duaa Uzair; Abdul Raheem Malik; Rana Ali Mustafa; Safi Ur Rehman DaimShow moreShow less
1. Department of Medicine, Services Institute of Medical Sciences, Lahore, Pakistan; 2. Department of Medicine, Allama Iqbal Medical College, Lahore, Pakistan; 3. Department of Medicine, Foundation University Medical College, Islamabad, Pakistan; 4. Department of Medicine, Rashid Latif Medical College, Lahore, Pakistan; 5. Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan; 6. Department of Medicine, Continental Medical College, Lahore, Pakistan; 7. Carle Foundation Hospital, Illinois, USAShow moreShow less
FAQ
How long does EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY take to review a manuscript?
As of 2026-11-19, CrushSCI has 21 complete review records for EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. The fastest paper went from submission to acceptance in 13 days (Correspondence: Reply to “Heterogeneity in dosages and treatment conditions forms a blurred picture of the results”, received 2026-10-19, accepted 2026-11-01); the slowest took 176 days. The average is 95.0 days and the median is 102 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
